Back to Search
Start Over
Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
- Source :
- Journal of Enzyme Inhibition and Medicinal Chemistry, Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 34, Iss 1, Pp 1451-1456 (2019)
- Publication Year :
- 2019
-
Abstract
- Herein, we report the effect of nine FDA approved protease inhibitor drugs against a new HIV-1 subtype C mutant protease, E35D↑G↑S. The mutant has five mutations, E35D, two insertions, position 36 (G and S), and D60E. Kinetics, inhibition constants, vitality, Gibbs free binding energies are reported. The variant showed a decreased affinity for substrate and low catalytic efficiency compared to the wild type. There was a significant decrease in the binding of seven FDA approved protease inhibitors against the mutant (p
- Subjects :
- medicine.medical_treatment
Amprenavir
Inhibitory Concentration 50
thermodynamics
HIV Protease
Drug Discovery
medicine
HIV Protease Inhibitor
Protease inhibitor (pharmacology)
mutant
Pharmacology
Protease
Chemistry
lcsh:RM1-950
Wild type
HIV
General Medicine
HIV Protease Inhibitors
Molecular biology
Atazanavir
Molecular Docking Simulation
inhibitor
Kinetics
Nelfinavir
lcsh:Therapeutics. Pharmacology
Mutation
HIV-1
Ritonavir
medicine.drug
Research Paper
Subjects
Details
- ISSN :
- 14756374
- Volume :
- 34
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Journal of enzyme inhibition and medicinal chemistry
- Accession number :
- edsair.doi.dedup.....46ea6d69337a5b76639d02844439bf24